Anti‐thymocyte globulin induction with delayed introduction of tacrolimus preserves renal function in pediatric liver transplant recipients
Pediatric Transplantation · 2023
DOI: 10.1111/petr.14509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2023. Verfasst von Michael E Rogers und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Gastroenterology Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Tacrolimus, Liver Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NIDDK NIH HHS, National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Background
Tacrolimus (TAC)‐mediated renal disease occurs in up to 70% of pediatric liver transplant (LT) recipients. The safety and efficacy of renal‐sparing immunosuppression using anti‐thymocyte globulin (ATG) induction and delayed TAC administration has not been studied in children. We evaluated the safety and efficacy of ATG induction on preserving renal function in children within the first year (Y1) post‐LT in a single‐center retrospective cohort study.
Methods
Children under age 18 years of who received isolated LT from 2008 to 2020 with a GFR < 70 received renal‐sparing (RS) protocol consisting of ATG with methylprednisolone (MP), delayed TAC administration, lower initial TAC trough goals, and mycophenolate mofetil (MMF). The RS group was matched 1:2 by age and LT indication with standard immunosuppression (SI) group. Changes in renal function as well as adverse events within Y1 post‐LT were compared.
Results
Forty‐four pediatric patients were included in the analysis, of which 13 received RS. As expected, the RS group had significantly lower mean TAC trough levels at 30 days (10.3 vs. 13.2, p = .001) post‐LT. Renal function was significantly preserved at 6 (−0.26 vs. 0.21, p = .004) and 12 months (−0.33 vs. 0.11, p = .003) post‐LT in the RS versus SI group as measured by mean change in serum creatinine, with similar trends observed in eGFR and cystatin C. ACR, sepsis, viremia, graft loss and mortality occurred at similar rates in both RS and SI groups.
Conclusion
Induction immunosuppression with ATG and delayed TAC administration in children with renal impairment is safe and effectively preserves renal function during Y1 post‐LT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Gastroenterology Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Department of Pediatric General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
ORCID-Profile: Michael E Rogers, Anna L Peters
Förderung
- NICHD NIH HHS
- NIDDK NIH HHS
- National Institute of Child Health and Human Development
- National Institute of Diabetes and Digestive and Kidney Diseases
- Cincinnati Children's Hospital Medical Center
Zitieren
APA
Rogers, M. E., Ambrosino, T., Hatcher, L., Bondoc, A., Tiao, G., & Peters, A. L. (2023). Anti‐thymocyte globulin induction with delayed introduction of tacrolimus preserves renal function in pediatric liver transplant recipients. Pediatric Transplantation. https://doi.org/10.1111/petr.14509
Vancouver
Rogers ME, Ambrosino T, Hatcher L, Bondoc A, Tiao G, Peters AL. Anti‐thymocyte globulin induction with delayed introduction of tacrolimus preserves renal function in pediatric liver transplant recipients. Pediatric Transplantation. 2023. doi:10.1111/petr.14509
BibTeX
@article{Rogers2023,
author = {Rogers, Michael E and Ambrosino, Teresa and Hatcher, Laura and Bondoc, Alex and Tiao, Greg and Peters, Anna L},
title = {Anti‐thymocyte globulin induction with delayed introduction of tacrolimus preserves renal function in pediatric liver transplant recipients},
journal = {Pediatric Transplantation},
year = {2023},
doi = {10.1111/petr.14509}
}
EUVIMED